These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 30227106)

  • 1. Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases.
    Seo YE; Ryu H; Oh JJ; Jeong SJ; Hwang SI; Lee HJ; Hong SK; Byun SS; Lee SE; Lee S
    Surg Infect (Larchmt); 2018 Oct; 19(7):704-710. PubMed ID: 30227106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
    Lee JK; Lee S; Hong SK; Byun SS; Lee SE
    BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate.
    Siyez E
    Medicine (Baltimore); 2021 Oct; 100(41):e27539. PubMed ID: 34731153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
    Seitz M; Stief C; Waidelich R; Bader M; Tilki D
    World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious complications following transrectal ultrasound-guided prostate biopsy: a Canadian tertiary cancer center experience.
    Al-Busaidi I; Leis JA; Gold WL; McGeer A; Toi A
    Infect Control Hosp Epidemiol; 2015 May; 36(5):614-6. PubMed ID: 25703214
    [No Abstract]   [Full Text] [Related]  

  • 9. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
    Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
    Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer.
    Ganeswaran D; Sweeney C; Yousif F; Lang S; Goodman C; Nabi G
    World J Urol; 2014 Apr; 32(2):309-15. PubMed ID: 22736233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
    Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
    Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
    Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
    J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraprostatic prophylactic antibiotic injection in patients undergoing transrectal ultrasonography-guided prostate biopsy.
    Shobeirian F; Zerafatjou N; Ghomi Z; Vafaei M; Darabi M
    Int J Urol; 2021 Jun; 28(6):683-686. PubMed ID: 33665862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy.
    Abughosh Z; Margolick J; Goldenberg SL; Taylor SA; Afshar K; Bell R; Lange D; Bowie WR; Roscoe D; Machan L; Black PC
    J Urol; 2013 Apr; 189(4):1326-31. PubMed ID: 23041343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
    Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
    Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.